4.4 Review

Epidemiology of Fractures in Diabetes

Journal

CALCIFIED TISSUE INTERNATIONAL
Volume 100, Issue 2, Pages 109-121

Publisher

SPRINGER
DOI: 10.1007/s00223-016-0175-x

Keywords

Diabetes mellitus; Fracture; Risk factors; Epidemiology

Funding

  1. Danish Council for Independent Research

Ask authors/readers for more resources

Diabetes mellitus is associated with an increased risk of fracture. The risk of a hip fracture is up to sevenfold increased in patients with type 1 diabetes and about 1.3-fold increased in patients with type 2 diabetes. However, these relative risk estimates may depend on the age and gender distribution of the population in question. Bone mineral density and the fracture risk assessment tool do not explain the increased fracture risk in patients with diabetes. Shared risk factors as pancreatitis, alcohol use, smoking and oral glucocorticoids may influence the observed fracture risk in patients with diabetes. This review examines the association between diabetes and fracture and attempts to disentangle the tight connection between diabetes per se, diabetes-related complications, comorbidities and shared risk factors. This is of great importance as the number of diabetes patients' increases with growing and aging populations and putting even more at risk of fracture.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Fractures following pregnancy in Osteogenesis imperfecta - A self-controlled case series using Danish Health Registers

Emilie Karense Lykking, Heidi Kammerlander, Fleur S. van Dijk, Daniel Prieto-Alhambra, Bo Abrahamsen, Lars Folkestad

Summary: This study found that there was no increased risk of fractures during pregnancy and 12 or 19 months postpartum compared to 12 or 19 months prior to conception.
Article Endocrinology & Metabolism

GIP reduces osteoclast activity and improves osteoblast survival in primary human bone cells

Morten S. Hansen, Kent Soe, Line L. Christensen, Paula Fernandez-Guerra, Nina W. Hansen, Rachael A. Wyatt, Claire Martin, Rowan S. Hardy, Thomas L. Andersen, Jacob B. Olesen, Bolette Hartmann, Mette M. Rosenkilde, Moustapha Kassem, Alexander Rauch, Caroline M. Gorvin, Morten Frost

Summary: Drugs targeting the GIP receptor have potential as treatments for type-2 diabetes and obesity. GIP can directly act on human bone cells to inhibit bone resorption, increase bone formation, and improve osteoblast survival. Therefore, these drugs may reduce bone resorption while preserving bone formation.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Low Bone Turnover Associates With Lower Insulin Sensitivity in Newly Diagnosed Drug-Naive Persons With Type 2 Diabetes

Mohamad Nasser, Jacob Stidsen, Kurt Hojlund, Jens Steen Nielsen, Richard Eastell, Morten Frost

Summary: The study found that bone turnover markers are lower in individuals with type 2 diabetes, and their levels are associated with insulin sensitivity. Among the three phenotypes of type 2 diabetes, individuals with the insulinopenic phenotype have higher levels of bone turnover markers. The conclusion is that bone turnover markers are lower in newly diagnosed individuals with type 2 diabetes characterized by low insulin sensitivity.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Review Medicine, General & Internal

Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia

Suzanne M. Jan de Beur, Salvatore Minisola, Wei-Bo Xia, Bo Abrahamsen, Jean-Jacques Body, Maria Luisa Brandi, Roderick Clifton-Bligh, Michael Collins, Pablo Florenzano, Pascal Houillier, Yasuo Imanishi, Erik A. Imel, Aliya A. Khan, M. Carola Zillikens, Seiji Fukumoto

Summary: Tumor-induced osteomalacia (TIO) is a rare condition caused by tumors that secrete fibroblast growth factor 23 (FGF23), leading to bone pain, muscle weakness, and low levels of vitamin D. Limited awareness of TIO among the medical community often leads to delayed diagnosis and poor outcomes. A global guidance document has been developed to improve knowledge and facilitate appropriate diagnosis, referral, and treatment of TIO. Key recommendations include measuring phosphate levels, conducting physical examinations to identify potential tumors, and utilizing functional imaging for tumor localization.

JOURNAL OF INTERNAL MEDICINE (2023)

Article Endocrinology & Metabolism

Primary hyperparathyroidism and fracture probability

John A. Kanis, Nicholas C. Harvey, Enwu Liu, Liesbeth Vandenput, Mattias Lorentzon, Eugene McCloskey, Roger Bouillon, Bo Abrahamsen, Lars Rejnmark, Helena Johansson

Summary: Patients with primary hyperparathyroidism have increased incidence of hip and major osteoporotic fractures, even if not referred for parathyroidectomy. The risk of death is also increased, which affects fracture probability. These findings support the need to widen the indications for parathyroidectomy in mild primary hyperparathyroidism.

OSTEOPOROSIS INTERNATIONAL (2023)

Article Endocrinology & Metabolism

Healthcare costs associated with opportunistically identifiable vertebral fractures

Michael Kriegbaum Skjodt, Joeri Nicolaes, Christopher Dyer Smith, Cesar Libanati, Cyrus Cooper, Kim Rose Olsen, Bo Abrahamsen

Summary: This study examines the direct healthcare costs of subjects with vertebral fractures available for identification on routine CT scans. The results show that patients with vertebral fractures incur significantly higher healthcare costs compared to those without fractures. The study also found that the healthcare costs per day at risk were higher in the short term for patients with vertebral fractures, although this difference was not statistically significant, and the long-term healthcare costs were similar to the general population.
Review Endocrinology & Metabolism

New Insights in the Pathophysiology, Epidemiology, and Response to Treatment of Osteoporotic Vertebral Fractures

Michael Kriegbaum Skjodt, Bo Abrahamsen

Summary: This article summarizes the recent advances in the understanding of vertebral fractures, with a focus on endocrine diseases, prevention, and treatment. It highlights the increased risk of vertebral fractures in patients with endocrine diseases and the current focus on invasive treatments. It also mentions that licensed treatments are effective in reducing the occurrence of vertebral fractures in osteoporosis patients.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Review Medicine, General & Internal

Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials

Mina Nicole Handel, Isabel Cardoso, Cecilie von Bulow, Jeanett Friis Rohde, Anja Ussing, Sabrina Mai Nielsen, Robin Christensen, Jean-Jacques Body, Maria Luisa Brandi, Adolfo Diez-Perez, Peyman Hadji, Muhammad Kassim Javaid, Willem Frederik Lems, Xavier Nogues, Christian Roux, Salvatore Minisola, Andreas Kurth, Thierry Thomas, Daniel Prieto-Alhambra, Serge Livio Ferrari, Bente Langdahl, Bo Abrahamsen

Summary: This study aimed to review the comparative effectiveness of osteoporosis treatments, including the bone anabolic agents, abaloparatide and romosozumab, on reducing the risk of fractures in postmenopausal women, and to characterize the effect of antiosteoporosis drug treatments on the risk of fractures according to baseline risk factors. The results showed that osteoporosis treatments had a protective effect on reducing fracture risk, and bone anabolic agents were more effective than bisphosphonates.

BMJ-BRITISH MEDICAL JOURNAL (2023)

Article Biology

'Skeletal Age' for mapping the impact of fracture on mortality

Thach Tran, Thao Ho-Le, Dana Bliuc, Bo Abrahamsen, Louise Hansen, Peter Vestergaard, Jacqueline R. Center, Tuan Nguyen

Summary: The concept of "Skeletal Age" is introduced to convey the combined risk of fracture and fracture-associated mortality. Skeletal Age is defined as the sum of chronological age and the number of years of life lost associated with a fragility fracture. The study found that men tend to lose more years of life after a fragility fracture than women, and hip fractures result in the greatest loss of life years.

ELIFE (2023)

Article Clinical Neurology

Epidemiological Factors Associated with Prescription of Opioids for Chronic Non-Cancer Pain in Adults: A Country-Wide, Registry-Based Study in Denmark Spans 2004-2018

Carrinna Aviaja Hansen, Martin Thomsen Ernst, Christopher Dyer Smith, Bo Abrahamsen

Summary: This study aimed to characterize the epidemiological risk factors associated with long-term non-cancer opioid use among Danish citizens. The findings revealed that factors such as age, marital status, residence, and medication usage were associated with long-term opioid use. These findings are crucial for future revisions of treatment recommendations.

JOURNAL OF PAIN RESEARCH (2023)

Article Endocrinology & Metabolism

Fracture Risk in Men and Women With Vertebral Fractures Identified Opportunistically on Routine Computed Tomography Scans and Not Treated for Osteoporosis: An Observational Cohort Study

Michael Kriegbaum Skjodt, Joeri Nicolaes, Christopher Dyer Smith, Kim Rose Olsen, Cyrus Cooper, Cesar Libanati, Bo Abrahamsen

Summary: We evaluated the risk of subsequent fractures in individuals with vertebral fractures (VFs) identified on routine computed tomography (CT) scans. We found that subjects with VF had a higher risk of major osteoporotic fractures, especially hip fractures, compared to those without VF. This highlights the importance of systematic opportunistic screening and fracture risk management for this high-risk population.

JBMR PLUS (2023)

Article Endocrinology & Metabolism

Towards Improved Identification of Vertebral Fractures in Routine Computed Tomography (CT) Scans: Development and External Validation of a Machine Learning Algorithm

Joeri Nicolaes, Michael Kriegbaum Skjodt, Steven Raeymaeckers, Christopher Dyer Smith, Bo Abrahamsen, Thomas Fuerst, Marc Debois, Dirk Vandermeulen, Cesar Libanati

Summary: This study developed a machine learning algorithm to identify vertebral fractures in abdominal/chest CT scans and demonstrated its strong performance on an external validation set. It has the potential to support healthcare professionals with the early identification of vertebral fractures and prevention of future fragility fractures.

JOURNAL OF BONE AND MINERAL RESEARCH (2023)

Article Endocrinology & Metabolism

Microvascular Disease Associates with Larger Osteocyte Lacunae in Cortical Bone in Type 2 Diabetes Mellitus

Sebastian Zanner, Elliott Goff, Samuel Ghatan, Eva Maria Woelfel, Charlotte Ejersted, Gisela Kuhn, Ralph Mueller, Morten Frost

Summary: Clinical studies have shown that microvascular disease (MVD) can affect bone microstructure and decrease bone strength in patients with type 2 diabetes mellitus (T2D). This study collected bone biopsies from T2D patients and found that MVD may alter the morphometric parameters of osteocyte lacunae. Additionally, the study revealed that trabecular bone lacunar density was associated with glycated hemoglobin (HbA1c), independent of MVD.

JBMR PLUS (2023)

Article Endocrinology & Metabolism

Sex- and Age Group-Specific Fracture Incidence Rates Trends for Type 1 and 2 Diabetes Mellitus

Mohamad Nasser, Annika Vestergaard Kvist, Peter Vestergaard, Richard Eastell, Andrea M. Burden, Morten Frost

Summary: The study investigated the trends in fracture incidence rates among men and women with type 1 and type 2 diabetes. The results showed a decrease in fracture incidence rates in men with both types of diabetes and in women with type 2 diabetes, highlighting the need for further attention to the stable trend observed in women with type 1 diabetes.

JBMR PLUS (2023)

Article Health Care Sciences & Services

Explaining declining hip fracture rates in Norway: a population-based modelling study

Helena Kames Kjeldgaard, Kristin Holvik, Bo Abrahamsen, Grethe S. Tell, Haakon E. Meyer, Martin O'Flaherty

Summary: Although the age-standardised hip fracture incidence has declined in many countries, the number of fractures is expected to increase due to population aging. This study found that 91% of the decline in hip fractures can be explained by changes in risk factors and the promotion of osteoporosis treatment.

LANCET REGIONAL HEALTH-EUROPE (2023)

No Data Available